• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2024 Scientific Session Call For Abstracts
      • 2024 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2022
      • SAGES 2021
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Store
    • “Unofficial” Logo Products
  • Log In

Immunologic Efficacy of E39 & E39’ Vaccination in a Phase I/IIa Trial in Ovarian & Endometrial Cancer Patients

Jessica L Cindass, MD1, Annelies T Hickerson, MD1, Tommy A Brown II1, Kaitlin M Peace1, John W Myers III1, Timothy J Vreeland2, Diane F Hale1, Doreen O Jackson1, Julia M Greene3, John S Berry IV4, Guy T Clifton1, Garth S Herbert1, George E Peoples5. 1Brooke Army Medical Center, San Antonio, TX, 2University of Texas MD Anderson Cancer Center, Houston, TX, 3Tripler Army Medical Center, Honolulu, HI, 4Womack Army Medical Center, Fort Bragg, NC, 5Cancer Vaccine Development Program, San Antonio, TX

Background: The treatment options for cancer are ever-evolving and now include vaccines targeting tumor-specific immunogenic peptides to induce tumor cytolysis.  Folate binding protein (FBP) is a tumor-associated antigen (TAA) highly expressed in most endometrial and ovarian cancers, shielded from the normal immune system.  The most promising FBP peptides are E39 and an attenuated form, E39’ (aka J65).  In our most recent phase I/IIa trial we evaluated an E39+GM-CSF inoculation series at 3 doses (VG) vs controls (CG) as well as booster vaccination with E39 and or E39’ after the initial inoculation series.  Here we present the immunologic data from this phase I/IIa trial.

Methods: Patients with ovarian or endometrial cancer who were disease-free after standard of care therapy but at risk for recurrence were enrolled.  HLA-A2+ patients were enrolled in the VG, with the first 9 patients vaccinated in a 3+3 dose escalation of 100mcg, 500mcg, and 1000mcg, and the remaining patients receiving 1000mcg inoculations.  Vaccine was given every 3-4 weeks for a total of 6 doses.  Patients were then offered booster vaccination and randomized to receive E39 or E39’.  FBP expression level was measured on the resected disease.  Immunologic response was measured by delayed type hypersensitivity (DTH) and ELISPOT in the VG.

Results: A total of 29 patients were vaccinated, 9 patients received boosters with E39 and 9 with E39’.  Mean DTH prior to the initial dose of E39 was 5.74mm and after final dose was 10.33mm (p = 0.018).  Mean overall ELISPOT change over time through 18 months was +69.1 when compared to baseline (p=0.675).  At 18 months post vaccination, mean ELISPOT increased by +97.1 in 1000mcg vs -57.0 in in <1000mcg patients (p = 0.047).  At 18 months post vaccination, mean ELISPOT in patients with above average initial DTH increased by +255.33 from baseline, while those with below initial DTH showed a decrease from baseline of -0.75 (p = 0.004).  Immunological analyses were not significantly different between FBP high/low expression or E39 vs E39’ booster (p < 0.05).

Conclusions: E39 demonstrated significant overall immunogenicity on in vivo testing as measured by DTH. Ex vivo analysis (ELISPOT) suggests that E39 is more immunogenically efficacious in patients with baseline immunity to FBP (indicated by with > average initial DTH) and those who are optimally dosed (1000mcg).  FBP expression level and E39 vs E39’ use in booster inoculations did not significantly impact in vivo or ex vivo immunogenicity.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 94119

Program Number: MSS05

Presentation Session: Full-Day Military Surgical Symposium – Basic Science/Quality Improvement Presentations

Presentation Type: MSSPodium

38

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

« Return to SAGES 2019 abstract archive

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064
1-310-437-0544
sagesweb@sages.org
Monday - Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons